SmPC, PIL and Labelling Translation into Arabic for EDA, SFDA and MOHAP Submissions
An Arabic SmPC or patient leaflet is read twice: once by a regulatory assessor who checks it against the approved English text, and once by a patient standing in a pharmacy. Lingoarabia writes for both readers. Our regulatory work is led by Dr. Ola Siam, a pharmacist who has translated hundreds of leaflets and package inserts across cardiovascular, endocrine, respiratory, oncology and anti-infective products. It is the document type she has translated most in 17+ years of English to Arabic medical work.
What we translate for registration and maintenance
- Summaries of product characteristics (SmPC) and prescribing information
- Patient information leaflets (PIL), package inserts and medication guides
- Outer and inner labelling, carton and blister text, artwork text for mock-ups
- Module 1 regional documents: application forms, cover letters, declarations, product information
- Administrative and summary sections of the CTD where the authority requires Arabic
- Variation submissions, safety updates to labelling and renewal packages
- Certificates, GMP and free-sale documents for legalisation
- Responses to agency queries and deficiency letters
We translate for submissions to the Egyptian Drug Authority (EDA), the Saudi Food and Drug Authority (SFDA), the UAE Ministry of Health and Prevention (MOHAP) and the GCC centralised procedure, and we keep the register and template wording each authority expects.
How regulatory text is handled
Labelling is translated by a pharmacist linguist, revised independently by a second linguist and checked in Xbench against the product glossary and the reference SmPC. This ISO 17100-aligned process is the same one we run for a device manufacturer’s quality system, and Dr. Siam meets the translator qualification criteria of ISO 17100:2015, clause 3.1.4 (b) and (c).
Two things separate regulatory translation from ordinary medical work. The first is register. Arabic labelling has its own phrasing for contraindications, posology and warnings, and text that is correct in English can still be wrong for the Arabic regulatory register. The second is the proof. Approved Arabic text often breaks in the typeset artwork: letters stop joining, numerals flip, a bracket moves to the wrong side. We check the typeset proof before it goes to print, which is where most late corrections come from.
Who does the work
Dr. Ola Siam holds a B.Pharm. from Assiut University (2004) and is a ProZ.com Certified PRO. Her archive records 1,835 medical and pharmaceutical projects, 5.8 million words, including 243 clinical and regulatory documentation projects. Between 2011 and 2012 she worked in pharmaceutical practice on biosimilar and generic product documentation alongside an in-house senior translator post, so she has read labelling from the pharmacy counter as well as the translation desk. Since 2016 she has worked under direct contract with a global medical-device manufacturer inside its quality management system, SOPs and audits, name withheld under NDA.
What the authorities expect from Arabic labelling
EDA, SFDA and MOHAP all require Arabic patient information for registration, and each has a preferred structure for the leaflet. Assessors compare the Arabic against the approved English source section by section. Common reasons for a query are missing or reordered sections, a dose expressed differently in the two languages, and a brand or INN written inconsistently across the SmPC, PIL and carton.
We maintain a product glossary from the first file onward, so the INN, excipients, strengths and pack sizes read the same on every component. For products already on the market, we align with the approved Arabic wording you supply and flag any place where the English has changed since.
Arabic errors we catch
- Posology where “once daily” and “every other day” have been merged by a careless rendering
- Contraindications softened into cautions by the choice of verb
- Excipient names transliterated inconsistently between the SmPC and the PIL
- Storage conditions with Celsius values reversed in right-to-left layout
- Pregnancy and lactation warnings written in a register patients do not read as warnings
- Section headings that do not match the authority’s leaflet template
These errors cost minutes to fix before a submission and months after it, which is why the independent revision step is never skipped on labelling.
Capacity, tools and delivery
One senior linguist translates 4,000 to 5,000 words a day and reviews 7,000 words a day. A full product set (SmPC, PIL, carton and blister text) typically fits in one working week including revision and proof check. We work in Trados Studio, memoQ, Wordfast Pro and XTM, accept Word and XML exports from your regulatory system, and return a translation memory and termbase with every delivery.
For a product set or a variation, send the approved English source and any existing Arabic text through the quote request form. You will get a scoped reply with a delivery date during Cairo working hours.
Frequently asked questions
Yes. We structure the Arabic PIL to the template the authority uses and keep the section headings in the order the assessor expects. If your regulatory affairs team has a house template, we work to that instead.
Yes. We take the approved Arabic as the baseline, translate only the changed English segments and deliver a tracked-changes file so the assessor sees exactly what moved. The translation memory keeps the approved wording intact.
Yes, and we recommend it for every component. We check right-to-left layout, letter joining, numerals, line breaks and mixed Arabic and Latin text on the final proof. We review the proof; we do not typeset it.
Egypt (EDA), Saudi Arabia (SFDA), the UAE (MOHAP, Department of Health Abu Dhabi and Dubai Health Authority) and the GCC centralised procedure. The same Modern Standard Arabic text is accepted across the region, with market-specific wording where an authority asks for it.
A pharmacist. Dr. Ola Siam translates or revises every SmPC personally, and the second linguist on labelling is also a life-sciences specialist. Pharmacology, pharmacokinetics and undesirable-effects sections are not passed to generalists.
Yes. We provide a signed statement of accuracy naming the document, version and date for inclusion in Module 1. We also sign your NDA before receiving any dossier section.